PATTERN OF NEUROBEHAVIORAL DEFICITS ASSOCIATED WITH INTERFERON-ALFA THERAPY FOR LEUKEMIA

被引：136
|
作者：
PAVOL, MA
MEYERS, CA
REXER, JL
VALENTINE, AD
MATTIS, PJ
TALPAZ, M
机构：
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT NEUROONCOL,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT CLIN IMMUNOL & BIOL THERAPY,HOUSTON,TX 77030
来源：
NEUROLOGY | 1995年 / 45卷 / 05期
关键词：
D O I：
10.1212/WNL.45.5.947
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
We evaluated the neuropsychological and personality profiles of 25 patients with chronic myelogenous leukemia treated with interferon alfa (IFN-alpha). This group of persons performed well below expectation on tests of cognitive speed, verbal memory, and executive functions. Personality changes included depression, increased somatic concern, and stress reactions. A control group of leukemia patients not treated with IFN-alpha had significantly better cognitive speed and mood. The pattern of cognitive and personality changes in patients receiving IFN-alpha is highly suggestive of frontal-subcortical brain dysfunction.
引用
收藏
页码：947 / 950
页数：4
相关论文
共 50 条
  • [21] Interferon-alfa, interferon-λ and hepatitis C
    Thomas R O'Brien
    Nature Genetics, 2009, 41 : 1048 - 1050
  • [22] INTERFERON-ALFA HAS BECOME A STANDARD IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA
    FREUND, M
    HUBER, C
    SEMINARS IN HEMATOLOGY, 1993, 30 (03) : 1 - 5
  • [23] Results of interferon-alfa therapy in patients with Behçet uveitis
    Ilknur Tugal-Tutkun
    Esra Güney-Tefekli
    Meri Urgancioglu
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2006, 244 : 1692 - 1695
  • [24] Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders
    Beretta, L
    Caronni, M
    Vanoli, M
    Scorza, R
    BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (02) : 385 - 386
  • [25] Is it time to make interferon-alfa first-line therapy?
    Kiladjian, J. J.
    LEUKEMIA RESEARCH, 2016, 44 : S9 - S10
  • [26] Interferon-alfa, interferon-λ and hepatitis C
    O'Brien, Thomas R.
    NATURE GENETICS, 2009, 41 (10) : 1048 - 1050
  • [27] Early treatment decisions with interferon-alfa therapy in early chronic-phase chronic myelogenous leukemia
    Sacchi, S
    Kantarjian, HM
    Smith, TL
    O'Brien, S
    Pierce, S
    Kornblau, S
    Beran, M
    Keating, MJ
    Talpaz, M
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) : 882 - 889
  • [28] An adolescent with HTLV-I-associated adult T cell leukemia treated with interferon-alfa and zidovudine
    Broniscer, A
    Ribeiro, RC
    Srinivas, RV
    Behm, FG
    Head, DR
    Raimondi, SC
    Mandrell, B
    Gill, P
    LEUKEMIA, 1996, 10 (07) : 1244 - 1248
  • [29] RHABDOMYOLYSIS AFTER TREATMENT WITH INTERFERON-ALFA
    GREENFIELD, SM
    HARVEY, RS
    THOMPSON, RPH
    BRITISH MEDICAL JOURNAL, 1994, 309 (6953): : 512 - 512
  • [30] A heightened global response of interferon-alfa treatment on host gene transcription is associated with clearance of HCV after interferon therapy
    He, XS
    Ji, XH
    Cheung, R
    Pfeffer, LM
    Tibshirani, R
    Greenberg, HB
    GASTROENTEROLOGY, 2004, 127 (01) : 332 - 333
12345